vMap® Clinical Studies
Procedural Enhancements
Associated with 23% reduction in total procedure time 18% Lift in procedural throughput
IMPACT FOR AF
PVI+DRIVERS
vMap use associated with significant improvement in arrhythmia-free survival3
IMPACT FOR VT
UNSTABLE
vMap use associated with significantly decreased VT recurrence or death4
The vMap Study
Forward-Solution Noninvasive Computational Arrhythmia Analysis
Blinded, multi-center, and independently adjudicated study with 225 patients
Atrial and ventricular arrhythmias were studied, as well as pacing
Hypothesis: vMap can help identify the locations of arrhythmias and pacing
vMap compared to ’gold standard’ site of successful ablation or pacing during EP study and ablation
Conclusions: Computational ECG mapping using a forward-solution approach exceeded pre-specified accuracy goals for arrhythmia and pacing localization. Spatial accuracy analysis demonstrated clinically actionable results. This rapid, noninvasive mapping technology may facilitate catheter-based and noninvasive targeted arrhythmia therapies.’
The vMap Time Study
Impact of artificial intelligence arrhythmia mapping on timeto first ablation, procedure duration, and fluoroscopy use
A study to compare procedure metrics for the first vMap cases with pre-vMap cases
Cases matched by operator, institution, arrhythmia type and case complexity
Key findings
Impact for AF
Success rates of ECG mapping for PVI + Atrial Fibrillation Drivers
Recurrent AF is common, hypothesis that ECG mapping + PVI may identify AF drivers better than PVI alone
27 study patients and 54 control patients (PVI only) with median 6-month follow-up
Patients had persistent AF, recurrent AF after prior ablation, or AF associated with atrial flutter or focal atrial tachycardia.
Key finding
Impact for VT
Outcome improvements associated with vMap in Unstable VT
Multi-center study of consecutive patients undergoing ablation for unstable VT against historical control adjusted for age, EF % and ischemic cardiomyopathy
Out of 32 consecutive patients undergoing ECG mapping guided VT ablation, 26 had unstable VT
6-month follow-up
Key findings
The results were not impacted by lead placement or patient anatomy2
Radio-Ablation Planning Study Utilizing vMap
Computational ECG mapping and respiratory gating to optimize stereotactic ablative radiotherapy workflow for refractory ventricular tachycardia.
This peer-reviewed article concluded that vMap and protocol-based respiratory gating may help facilitate radioablation planning and maintain efficacy during therapy.
The prospective, dual-site study reported that a new non-invasive workflow using vMap may help facilitate the radioablation planning workflow. The study concluded that radio-ablation using vMap’s 12-lead ECG mapping and respiratory gated delivery may provide short-term safety and maintain efficacy during therapy in patients with advanced structural heart disease and refractory ventricular tachycardia.*